XLON:SAR
Sareum Holdings Plc Stock Company Profile
£20.50
+4.00 (+24.24%)
At Close: Apr 17, 2024
Information
Langford Arch, Unit 2A London Road Pampisford
Cambridge CAMBRIDGESHIRE CB22 3FX
44 1223 497 700
www.sareum.com
Industry: Biotechnology
Sector: Healthcare
Description
Sareum Holdings plc, a specialist drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's product pipeline includes Checkpoint Kinase 1, Aurora+FLT3 kinase, and TYK2/JAK1 kinase. It has collaborations with Hebei Medical University Biomedical Engineering Center and Sierra Oncology, Inc. The company was founded in 2003 and is based in Cambridge, the United Kingdom.
